MedicaidPrior AuthMedium impact
Jemperli (dostarlimab-gxly) (New)
Humana·LA · Oncology, Hematology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana has implemented a new prior authorization policy for Jemperli (dostarlimab-gxly), an IV oncology medication used for endometrial cancer and certain solid tumors. This policy applies to Louisiana Medicaid patients and requires prior authorization for all uses of this specialty cancer drug.
Action Required
By November 1, 2025: Oncology practices treating Louisiana Medicaid patients must obtain prior authorization before administering Jemperli (dostarlimab-gxly). Update billing workflows to verify authorization requirements and ensure all criteria are met before treatment. Claims will be denied without proper prior authorization.